259 related articles for article (PubMed ID: 23822434)
1. In vivo measurements for high dose rate brachytherapy with optically stimulated luminescent dosimeters.
Sharma R; Jursinic PA
Med Phys; 2013 Jul; 40(7):071730. PubMed ID: 23822434
[TBL] [Abstract][Full Text] [Related]
2. Development and implementation of a remote audit tool for high dose rate (HDR) Ir-192 brachytherapy using optically stimulated luminescence dosimetry.
Casey KE; Alvarez P; Kry SF; Howell RM; Lawyer A; Followill D
Med Phys; 2013 Nov; 40(11):112102. PubMed ID: 24320455
[TBL] [Abstract][Full Text] [Related]
3. Suitability of microDiamond detectors for the determination of absorbed dose to water around high-dose-rate
Kaveckyte V; Malusek A; Benmakhlouf H; Alm Carlsson G; Carlsson Tedgren Å
Med Phys; 2018 Jan; 45(1):429-437. PubMed ID: 29171060
[TBL] [Abstract][Full Text] [Related]
4. In vivo dosimetry with optically stimulated luminescent dosimeters, OSLDs, compared to diodes; the effects of buildup cap thickness and fabrication material.
Jursinic PA; Yahnke CJ
Med Phys; 2011 Oct; 38(10):5432-40. PubMed ID: 21992362
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of an OSLD in the diagnostic energy range.
Al-Senan RM; Hatab MR
Med Phys; 2011 Jul; 38(7):4396-405. PubMed ID: 21859040
[TBL] [Abstract][Full Text] [Related]
6. Varian HDR surface applicators - commissioning and clinical implementation.
Iftimia I; McKee AB; Halvorsen PH
J Appl Clin Med Phys; 2016 Mar; 17(2):231-248. PubMed ID: 27074486
[TBL] [Abstract][Full Text] [Related]
7. In vivo dosimetry for gynaecological brachytherapy using a novel position sensitive radiation detector: feasibility study.
Reniers B; Landry G; Eichner R; Hallil A; Verhaegen F
Med Phys; 2012 Apr; 39(4):1925-35. PubMed ID: 22482614
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of linear array MOSFET detectors for in vivo dosimetry to measure rectal dose in HDR brachytherapy.
Haughey A; Coalter G; Mugabe K
Australas Phys Eng Sci Med; 2011 Sep; 34(3):361-6. PubMed ID: 21710233
[TBL] [Abstract][Full Text] [Related]
9. A generic high-dose rate (192)Ir brachytherapy source for evaluation of model-based dose calculations beyond the TG-43 formalism.
Ballester F; Carlsson Tedgren Å; Granero D; Haworth A; Mourtada F; Fonseca GP; Zourari K; Papagiannis P; Rivard MJ; Siebert FA; Sloboda RS; Smith RL; Thomson RM; Verhaegen F; Vijande J; Ma Y; Beaulieu L
Med Phys; 2015 Jun; 42(6):3048-61. PubMed ID: 26127057
[TBL] [Abstract][Full Text] [Related]
10. Characterization of optically stimulated luminescent dosimeters, OSLDs, for clinical dosimetric measurements.
Jursinic PA
Med Phys; 2007 Dec; 34(12):4594-604. PubMed ID: 18196786
[TBL] [Abstract][Full Text] [Related]
11. Validation of OSLD and a treatment planning system for surface dose determination in IMRT treatments.
Zhuang AH; Olch AJ
Med Phys; 2014 Aug; 41(8):081720. PubMed ID: 25086530
[TBL] [Abstract][Full Text] [Related]
12. Design and testing of a phantom and instrumented gynecological applicator based on GaN dosimeter for use in high dose rate brachytherapy quality assurance.
Guiral P; Ribouton J; Jalade P; Wang R; Galvan JM; Lu GN; Pittet P; Rivoire A; Gindraux L
Med Phys; 2016 Sep; 43(9):5240. PubMed ID: 27587055
[TBL] [Abstract][Full Text] [Related]
13. Monte Carlo study of the relationship between skin dose and optically stimulated luminescence dosimeter dose in Pd-103 permanent breast seed implant brachytherapy.
Nich S; Kirkby C; Villarreal-Barajas JE
Brachytherapy; 2019; 18(3):387-395. PubMed ID: 30792005
[TBL] [Abstract][Full Text] [Related]
14. Dosimetric characterisation of the optically-stimulated luminescence dosimeter in cobalt-60 high dose rate brachytherapy system.
Rejab M; Wong JHD; Jamalludin Z; Jong WL; Malik RA; Wan Ishak WZ; Ung NM
Australas Phys Eng Sci Med; 2018 Jun; 41(2):475-485. PubMed ID: 29756166
[TBL] [Abstract][Full Text] [Related]
15. In vivo dosimetry in the urethra using alanine/ESR during (192)Ir HDR brachytherapy of prostate cancer--a phantom study.
Anton M; Wagner D; Selbach HJ; Hackel T; Hermann RM; Hess CF; Vorwerk H
Phys Med Biol; 2009 May; 54(9):2915-31. PubMed ID: 19384000
[TBL] [Abstract][Full Text] [Related]
16. Optically stimulated luminescent dosimeters stable response to dose after repeated bleaching.
Jursinic PA
Med Phys; 2020 Jul; 47(7):3191-3203. PubMed ID: 32297332
[TBL] [Abstract][Full Text] [Related]
17. Determination of absorbed dose to water around a clinical HDR (192)Ir source using LiF:Mg,Ti TLDs demonstrates an LET dependence of detector response.
Carlsson Tedgren A; Elia R; Hedtjarn H; Olsson S; Alm Carlsson G
Med Phys; 2012 Feb; 39(2):1133-40. PubMed ID: 22320824
[TBL] [Abstract][Full Text] [Related]
18. Development of a phantom to validate high-dose-rate brachytherapy treatment planning systems with heterogeneous algorithms.
Moura ES; Micka JA; Hammer CG; Culberson WS; DeWerd LA; Rostelato ME; Zeituni CA
Med Phys; 2015 Apr; 42(4):1566-74. PubMed ID: 25832047
[TBL] [Abstract][Full Text] [Related]
19. Characterization and use of a 2D-array of ion chambers for brachytherapy dosimetric quality assurance.
Yewondwossen M
Med Dosim; 2012; 37(3):250-6. PubMed ID: 22189031
[TBL] [Abstract][Full Text] [Related]
20. SU-E-T-312: Optically Stimulated Luminescent Dosimeter Performance in High Dose Rate Brachytherapy.
Tien C; Hiatt J; Curran B; Sternick E
Med Phys; 2012 Jun; 39(6Part14):3775. PubMed ID: 28517245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
